FDA's Overreach on Compounded Peptides Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? Why Are People Injecting Themselves with Peptides? The New Yorker BPC 157: Experimental Peptide Creates Risk for Athletes